March 21, 2017
Webinar
As courts apply the Supreme Court’s direction on willful infringement, U.S. companies have guideposts to look to on the bounds in which they can operate. For in-house counsel with a budget, obtaining an opinion letter for protection can be a challenge. Additionally, medical device companies often face issues relating to patent exhaustion and whether medical devices can be limited to a single use. With the state of law in flux and the Supreme Court’s consideration of those issues to be heard, how should your company operate in the interim, and how might your actions under changing laws factor into the willfulness analysis?
Please join our panelists as they answer these questions and discuss the following topics:
Moderator:
J. Michael Jakes
Kathleen A. Daley
Justin A. Hendrix
Tuesday, March 21, 2017
10:00 - 11:00 a.m. PDT
1:00 - 2:00 p.m. EDT
Scheduling Conflict? Finnegan records all hosted webinars. To view the recorded program, simply register for the webinar and you will receive an access link shortly after the live program is complete.
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
INCONTESTABLE® Blog
Netflix Prevails in Copyright Infringement Suit Regarding Tiger King
May 14, 2026
Panel Discussion
May 5, 2026
London
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.